General Information of Binding Target of SBP (BTS) (ID: ST00068)
BTS Name
Tumor necrosis factor receptor superfamily member 9
Synonyms
4-1BB ligand receptor; CDw137; T-cell antigen 4-1BB homolog; T-cell antigen ILA; CD antigen CD137
BTS Type
Protein
Gene Name
TNFRSF9
Organism
Homo sapiens (Human)
Function
Receptor for TNFSF9/4-1BBL. Possibly active during T cell activation.
UniProt ID
Q07011
UniProt Entry
TNR9_HUMAN
PFam
PF00020
Gene ID
3604
Sequence
MGNSCYNIVATLLLVLNFERTRSLQDPCSNCPAGTFCDNNRNQICSPCPPNSFSSAGGQR
TCDICRQCKGVFRTRKECSSTSNAECDCTPGFHCLGAGCSMCEQDCKQGQELTKKGCKDC
CFGTFNDQKRGICRPWTNCSLDGKSVLVNGTKERDVVCGPSPADLSPGASSVTPPAPARE
PGHSPQIISFFLALTSTALLFLLFFLTLRFSVVKRGRKKLLYIFKQPFMRPVQTTQEEDG
CSCRFPEEEEGGCEL
Sequence Length
255
Synthetic Binding Protein (SBP) Targeting This BTS
SBP Name Highest Status Mechanism Affinity Application Details Ref
Anticalin Cinrebafusp alfa Phase I Agonist N.A. Solid tumour/cancer [ICD-11: 2A00-2F9Z]
SBP Info
[1], []
Bicyclic peptide anti-CD137 BT7401 Research Agonist N.A. Cancers [ICD-11: 2D4Z]
SBP Info
[2]
Bicyclic peptide anti-EphA2/CD137 BT7455 Research Agonist N.A. Cancers [ICD-11: 2D4Z]
SBP Info
[2]
Bicyclic peptide anti-Nectin-4/CD137 BT7480 Research Agonist N.A. Cancers [ICD-11: 2D4Z]
SBP Info
[2]
Bicyclic peptide BT7480 Phase II binder Kd: 6.3 nM Cancers [ICD-11: 2D4Z]
SBP Info
[3]
DARPin MP0310 Phase I Agonist N.A. Solid tumour/cancer [ICD-11: 2A00-2F9Z]
SBP Info
[4], [5]
References
1 Recent advances in the development of novel protein scaffolds based therapeutics. Int J Biol Macromol. 2017 Sep;102:630-641.
2 Bicycle therapeutics. Product Development Pipeline. 2021.
3 BT7480, a novel fully synthetic Bicycle tumor-targeted immune cell agonist? (Bicycle TICA?) induces tumor localized CD137 agonism. J Immunother Cancer. 2021 Nov;9(11):e002883.
4 Beyond Antibodies: The DARPin ? Drug Platform. BioDrugs. 2020 Aug;34(4):423-433.
5 Molecular Partners. Product Development Pipeline. 2021.